Taken together, these findings suggested that SMG‐1 modulation by miR‐192 and ‐215 is a functional tumorigenic pathway in GC, in agreement with findings for other tumor types 2, 3, 14, 17. This evidence concerns the gene SMG1 and neoplasm.